Voyageur Pharmaceuticals (CVE:VM) Shares Up 14.3% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares were up 14.3% during mid-day trading on Monday . The company traded as high as C$0.16 and last traded at C$0.16. Approximately 372,655 shares changed hands during mid-day trading, an increase of 42% from the average daily volume of 262,028 shares. The stock had previously closed at C$0.14.

Voyageur Pharmaceuticals Price Performance

The stock’s 50-day simple moving average is C$0.08 and its 200 day simple moving average is C$0.06. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company has a market cap of C$26.50 million, a price-to-earnings ratio of -19.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.